Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phlogosol
- Development stage
- Unknown
- Lead developer
- Pannonpharma
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
**Phlogosol** is an over-the-counter, fixed-dose topical oral and throat solution marketed by PannonPharma. It contains sodium samarium disulfosalicylate and hexachlorophene and is used locally as an antiseptic and anti-inflammatory preparation for inflammatory and infectious conditions of the mouth, pharynx, larynx, gingiva, and periodontal tissues, including recurrent aphthae and care surrounding dental extraction. The solution is diluted for mouth and throat rinsing or applied undiluted by brushing to the affected area. ([pannonpharma.hu](https://pannonpharma.hu/en/products/phlogosol))
- Brand names
- Phlogosol
- Other names
- Phlogosol external solutionPhlogosol külsőleges oldat
Beyond the preview
Go deeper on Phlogosol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Phlogosol.